Should You Buy Growth Stocks Right Now?

It's a scary time to be a growth investor. With the Federal Reserve aggressively hiking interest rates and the stock market in a steady decline, it's entirely rational to wonder whether it's a good idea to keep buying shares of growth-phase businesses.

And (spoiler alert) for some people, it might not be. Much depends on your risk tolerance and investment time frame. Let's examine Teladoc Health (NYSE: TDOC) as an example to explore which category of investor you might fall into during the ongoing disruption in the market and the economy.

Like many other growth stocks, Teladoc is down more than 88% over the last 12 months. This brutal decline might seem like the kind of result you'd expect from a company with shrinking revenue or severe and enduring headwinds, but neither is the case. Its quarterly revenue rose by around 25% over the last four quarters, and over the last three years, its quarterly sales increased by 334%.

Source Fool.com